HALO Growth 100 · Sector S2
Longevity & Healthspan
GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.
Equal-weight — 1d —
Cap-weighted — 1d —
Momentum (drift) — 1d —
Constituents — in this sector
Composite Index — since inception (Dec 30, 2025)
Three weighting variants of the same constituent basket, rebased to 1,000 at inception. EW = ticker-equal-weight with quarterly drift. CW = cap-weighted (10% cap; below ten names the cap is infeasible, so the sub-index is equal weight by construction) with semi-annual rebalance. MW = drift-only (1/N at inception, market does the tilting between rebalances). Click a legend entry to toggle its line.
Constituents
Every HALO 100 constituent tagged into this sector. Click a column header to sort (best to worst). Click a row to open the stock detail page in a new tab.
| Ticker | Company | Region | Last | 1d | 1w | 1m | 3m | 6m | 1y | CCY |
|---|---|---|---|---|---|---|---|---|---|---|
| ILMN | Illumina | NAM | 245.18 | +7.10% | +21.82% | +30.21% | +54.11% | +99.41% | +141.60% | USD |
| NTRA | Natera | NAM | 366.31 | +6.07% | +12.32% | +17.52% | +61.77% | +85.20% | +109.31% | USD |
| GXI.DE | Gerresheimer | EUR | 27.40 | -0.94% | -5.45% | -0.36% | +5.79% | +26.85% | -37.59% | EUR |
| VRTX | Vertex Pharma | NAM | 516.34 | +0.60% | +0.35% | -2.24% | +12.49% | +14.34% | +31.93% | USD |
| REGN | Regeneron | NAM | 789.45 | +1.92% | -0.48% | -2.57% | +29.86% | +6.09% | +37.62% | USD |
| NVO | Novo Nordisk | EUR | 43.19 | +3.55% | -1.86% | -5.51% | -0.76% | +19.56% | -21.72% | USD |
| LLY | Eli Lilly | NAM | 1152.44 | +1.28% | +2.62% | -5.98% | +3.64% | +25.53% | +51.18% | USD |
| AMGN | Amgen | NAM | 379.78 | +0.91% | -0.70% | -10.70% | +11.16% | +8.05% | +41.03% | USD |
| ZEAL.CO | Zealand Pharma | EUR | 282.90 | +3.66% | -0.46% | -11.98% | -0.21% | -0.11% | -31.40% | DKK |
| VKTX | Viking Therapeutics | NAM | 29.36 | -0.54% | -8.62% | -12.02% | -3.07% | -12.49% | +23.93% | USD |